Katarzyna Sidoryk

Dr. Katarzyna Sidoryk

orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 August 2018 in Molecules
Verified
Journal Article
Open access
PDF file
KSKatarzyna Sidoryk
Katarzyna Sidoryk
AJAnna Jaromin
Anna Jaromin
Nina FilipczakNina Filipczak
Nina Filipczak
PCPiotr Cmoch
Piotr Cmoch
Marcin CybulskiMarcin Cybulski
Marcin Cybulski
A series of caffeic acid derivatives were synthesized via a modified Wittig reaction which is a very important tool in organic chemistry for the construction of unsaturated carbon–carbon bonds. All reactions were performed in water medium at 90 °C. The aqueous Wittig reaction worked best when one unprotected hydroxyl group was present in the phenyl ring. The olefinations in the aqueous conditions were also conducted with good yields in the presence of two unprotected hydroxyl groups. When the number of the hydroxyl groups was increased to three, the reaction yields were worse, and the derivatives 12, 13, and 18 were obtained with 74%, 37%, and 70% yields, respectively. Nevertheless, the Wittig reaction using water as the essential medium is an elegant one-pot synthesis and a greener method, which can be a safe alternative for implementation in organic chemistry. The obtained compounds were tested for their antioxidant activity, and 12, 13, and 18 showed the highest activities. Moreover, all synthesized compounds displayed no cytotoxicity, and can therefore be used in the pharmaceutical or cosmetic industry.

1 November 2015 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
KSKatarzyna Sidoryk
Katarzyna Sidoryk
MŚMarta Świtalska
Marta Świtalska
AJAnna Jaromin
Anna Jaromin
PCPiotr Cmoch
Piotr Cmoch
IBIwona Bujak
Iwona Bujak
ŁKŁukasz Kaczmarek
Łukasz Kaczmarek

18 May 2012 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
KSKatarzyna Sidoryk
Katarzyna Sidoryk
MŚMarta Świtalska
Marta Świtalska
JWJoanna Wietrzyk
Joanna Wietrzyk
AJAnna Jaromin
Anna Jaromin
MPMagdalena Piętka-Ottlik
Magdalena Piętka-Ottlik
WPWanda Peczyńska-Czoch
Wanda Peczyńska-Czoch

1 May 2014 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
KSKatarzyna Sidoryk
Katarzyna Sidoryk
AJAnna Jaromin
Anna Jaromin
JEJessica A. Edward
Jessica A. Edward
MŚMarta Świtalska
Marta Świtalska
JSJoanna Stefańska
Joanna Stefańska
ŁKŁukasz Kaczmarek
Łukasz Kaczmarek

22 June 2021 in Cells
Verified
Journal Article
Open access
PDF file
AKAnna Kieronska-Rudek
Anna Kieronska-Rudek
AKAgnieszka Kij
Agnieszka Kij
PKPatrycja Kaczara
Patrycja Kaczara
ATAnna Tworzydlo
Anna Tworzydlo
MNMarek Napiorkowski
Marek Napiorkowski
SCStefan Chlopicki
Stefan Chlopicki
Vitamins K exert a range of activities that extend far beyond coagulation and include anti-inflammatory effects, but the mechanisms involved in anti-inflammatory action remain unclear. In the present study, we showed that various forms of exogenous vitamins—K1, K3, K2 (MK-4, MK-5, MK-6 and MK-7)—regulated a wide scope of inflammatory pathways in murine macrophages in vitro, including NOS-2, COX-2, cytokines and MMPs. Moreover, we demonstrated for the first time that macrophages are able to synthesise endogenous MK-4 on their own. Vitamins with shorter isoprenoid chains—K1, K3 and MK-5—exhibited stronger anti-inflammatory potential than vitamins with longer isoprenoid chains (MK-6 and MK-7) and simultaneously were preferably used as a substrate for MK-4 endogenous production. Most interesting, atorvastatin pretreatment inhibited endogenous MK-4 production but had no impact on the anti-inflammatory activity of vitamins K. In summary, our results demonstrate that macrophages are able to synthesise endogenous MK-4 using exogenous vitamins K, and statin inhibits this process. However, the anti-inflammatory effect of exogenous vitamins K was independent of endogenous MK-4 synthesis.

19 December 2020 in Materials
Verified
Journal Article
Open access
PDF file
MZMagdalena Zaremba-Czogalla
Magdalena Zaremba-Czogalla
AJAnna Jaromin
Anna Jaromin
KSKatarzyna Sidoryk
Katarzyna Sidoryk
Agnieszka ZagórskaAgnieszka Zagórska
Agnieszka Zagórska
Marcin CybulskiMarcin Cybulski
Marcin Cybulski
JGJerzy Gubernator
Jerzy Gubernator
Pancreatic cancer belongs to the most aggressive group of cancers, with very poor prognosis. Therefore, there is an important need to find more potent drugs that could deliver an improved therapeutic approach. In the current study we searched for selective and effective caffeic acid derivatives. For this purpose, we analyzed twelve compounds and evaluated their in vitro cytotoxic activity against two human pancreatic cancer cell lines, along with a control, normal fibroblast cell line, by the classic MTT assay. Six out of twelve tested caffeic acid derivatives showed a desirable effect. To improve the therapeutic efficacy of such active compounds, we developed a formulation where caffeic acid derivative (7) was encapsulated into liposomes composed of soybean phosphatidylcholine and DSPE-PEG2000. Subsequently, we analyzed the properties of this formulation in terms of basic physical parameters (such as size, zeta potential, stability at 4 °C and morphology), hemolytic and cytotoxic activity and cellular uptake. Overall, the liposomal formulation was found to be stable, non-hemolytic and had activity against pancreatic cancer cells (IC50 19.44 µM and 24.3 µM, towards AsPC1 and BxPC3 cells, respectively) with less toxicity against normal fibroblasts. This could represent a promising alternative to currently available treatment options.